Device recall · December 13, 2017
Dial-A-Dose Insulin Delivery Device recall
Why: A small number of batches may crack or break if exposed to certain chemicals, like certain cleaning agents.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Dial-A-Dose Insulin Delivery Device (Pen-Injector) cartridge holders Product Usage: The NovoPen Echo¿ is a re-usable pen injector for single patient use by diabetics for the self injection of a desired dose of insulin. The pen injector uses Penfill 3 mL cartridge of NovoLog¿, 100 units/mL (Ux100) [insulin aspart (rDNA origin) injection] and a single use detachable and disposable pen needle (supplied separately). The pen injector allows the user to dial the desired dose from 0.5 to 30 units in 0.5 increments.
- Lots / codes
U.S. batch numbers: EVG1221, EVG1226, FVG7149, FVG7458, FVG8134 & FVG8135
- Quantity
- 16,557 units
- Company
- Novo Nordisk Inc, Plainsboro, NJ
- Distribution
- Nationwide distribution
- Initiated
- July 5, 2017 · Voluntary: Firm initiated
- Classified
- December 7, 2017
- Reported
- December 13, 2017
- Ended
- April 9, 2019
- How notified
- Press Release
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.